YARDLEY, PA — Pennsylvania-based pharmaceutical company Optinose (NASDAQ: OPTN) has announced that its management team will be participating in the prestigious 35th Annual Piper Sandler Healthcare Conference. The presentation, which includes a comprehensive company overview and business update, is scheduled for November 29, 2023, at 3:30 p.m. ET.
The Piper Sandler Healthcare Conference is a well-recognized event in the healthcare sector, offering a platform for companies to connect with potential investors and industry peers. This year’s conference will host a range of presentations from leading companies within the healthcare industry, including Optinose.
Optinose, known for its focus on developing treatments for ear, nose, and throat conditions as well as allergies, has made significant strides in its respective field. The presentation by the management team is expected to provide valuable insights into the company’s current operations, future plans, and overall business strategy.
Those interested in tuning into the presentation can do so via a live webcast on the Investors page of the Optinose website. For individuals unable to attend the live webcast, a replay will be available for 60 days following the conclusion of the event, ensuring that investors have ample opportunity to catch up on the presentation.
This announcement comes on the heels of recent corporate updates from Optinose, which include financial results and other strategic developments. The company’s participation in the 35th Annual Piper Sandler Healthcare Conference marks another important milestone in its ongoing commitment to transparency and active engagement with the investor community.
The presentation is anticipated to provide both current and potential investors with a deeper understanding of Optinose’s growth strategy and market position within the pharmaceutical industry.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.